Accuray, Inc. (ARAY)
0.2668
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.269
0.00 (0.00%)
After-Hours: 20:00
Accuray Research and Development Expense (Quarterly) : 7.707M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.707M |
| March 31, 2026 | 8.178M |
| December 31, 2025 | 10.65M |
| September 30, 2025 | 11.27M |
| June 30, 2025 | 11.47M |
| March 31, 2025 | 10.71M |
| December 31, 2024 | 13.64M |
| September 30, 2024 | 12.12M |
| June 30, 2024 | 9.529M |
| March 31, 2024 | 10.91M |
| December 31, 2023 | 15.28M |
| September 30, 2023 | 14.01M |
| June 30, 2023 | 14.19M |
| March 31, 2023 | 14.21M |
| December 31, 2022 | 14.64M |
| September 30, 2022 | 14.09M |
| June 30, 2022 | 14.57M |
| March 31, 2022 | 14.10M |
| December 31, 2021 | 14.70M |
| September 30, 2021 | 14.38M |
| June 30, 2021 | 15.36M |
| March 31, 2021 | 13.27M |
| December 31, 2020 | 11.96M |
| September 30, 2020 | 12.15M |
| June 30, 2020 | 12.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.16M |
| December 31, 2019 | 13.06M |
| September 30, 2019 | 13.34M |
| June 30, 2019 | 16.05M |
| March 31, 2019 | 12.91M |
| December 31, 2018 | 13.34M |
| September 30, 2018 | 13.89M |
| June 30, 2018 | 14.59M |
| March 31, 2018 | 13.91M |
| December 31, 2017 | 14.66M |
| September 30, 2017 | 14.09M |
| June 30, 2017 | 13.26M |
| March 31, 2017 | 12.48M |
| December 31, 2016 | 11.94M |
| September 30, 2016 | 12.23M |
| June 30, 2016 | 14.16M |
| March 31, 2016 | 13.27M |
| December 31, 2015 | 14.93M |
| September 30, 2015 | 14.30M |
| June 30, 2015 | 14.85M |
| March 31, 2015 | 12.84M |
| December 31, 2014 | 13.92M |
| September 30, 2014 | 14.15M |
| June 30, 2014 | 13.58M |
| March 31, 2014 | 13.76M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |
| Rockwell Medical, Inc. | 0.04M |
| Microbot Medical, Inc. | 1.846M |